প্রকাশ: 23/01/2022
Pfizer Inc Chief Executive Albert Bourla said on Saturday
that an annual Covid-19 vaccine would be preferable to more frequent booster
shots in fighting the coronavirus pandemic.
Pfizer/BioNtech's Covid-19 vaccine has shown to be effective
against severe disease and death caused by the heavily-mutated Omicron variant
but less effective in preventing transmission.
With cases soaring, some countries have expanded Covid-19
vaccine booster programmes or shortened the gap between shots as governments
scramble to shore up protection.
In an interview with Israel's N12 News, Bourla was asked
whether he sees booster shots being administered every four to five months on a
regular basis.
"This will not be a good scenario. What I'm hoping (is)
that we will have a vaccine that you will have to do once a year," Bourla
said.
"Once a year - it is easier to convince people to do
it. It is easier for people to remember.
"So from a public health perspective, it is an ideal
situation. We are looking to see if we can create a vaccine that covers Omicron
and doesn't forget the other variants and that could be a solution,"
Bourla said.
প্রধান সম্পাদকঃ সৈয়দ বোরহান কবীর
ক্রিয়েটিভ মিডিয়া লিমিটেডের অঙ্গ প্রতিষ্ঠান
বার্তা এবং বাণিজ্যিক কার্যালয়ঃ ২/৩ , ব্লক - ডি , লালমাটিয়া , ঢাকা -১২০৭
নিবন্ধিত ঠিকানাঃ বাড়ি# ৪৩ (লেভেল-৫) , রোড#১৬ নতুন (পুরাতন ২৭) , ধানমন্ডি , ঢাকা- ১২০৯
ফোনঃ +৮৮-০২৯১২৩৬৭৭